Rivulet Entertainment (RIVF) 10-Q 12 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Oct. 29, 2019
Details
Registrant Name	Advanced Voice Recognition Systems, Inc.
Registrant CIK	0001342936
SEC Form	10-Q
Period End date	Sep. 30, 2019
Fiscal Year End	--12-31
Trading Symbol	AVOI
Tax Identification Number (TIN)	98-0511932
Number of common stock shares outstanding		276,020,268
Filer Category	Non-accelerated Filer
Current with reporting	Yes
Shell Company	true
Small Business	true
Emerging Growth Company	true
Ex Transition Period	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-52390
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	7659 E. Wood Drive,
Entity Address, City or Town	Scottsdale,
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85260
Entity Address, Address Description	(Address of principal executive offices)
City Area Code	(480)
Local Phone Number	704-4183
Title of 12(b) Security	Common Stock par value $0.001 per share
Security Exchange Name	NONE
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3

Balance Sheets (September 30, 2

Balance Sheets (September 30, 2019 Unaudited) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Current Assets
Cash and cash equivalents	$ 9,096	$ 17,583
Total Current Assets	9,096	17,583
Non-Current Assets
Patent, net	32,362	43,390
Total Non-Current Assets	32,362	43,390
Total Assets	41,458	60,973
Current Liabilities
Accounts payable	42,585	49,385
Payroll	162,382	162,382
Note Payable Meyer & Assoc.	0	19,100
Note Payable AIP	19,935	19,935
Note Payable Related Party	3,000	6,500
Accrued Interest	9,702	8,065
Total Current Liabilities	237,604	265,367
Stockholders' Deficit
Common Stock, Value	276,020	267,020
Additional paid-in capital	7,927,800	7,878,798
Accumulated Deficit	(8,399,966)	(8,350,212)
Total Stockholders' Deficit	(196,146)	(204,394)
Total Liabilities and Stockholders' Deficit	41,458	60,973
Liabilities
Total Liabilities	$ 237,604	$ 265,367

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Details
Sales		$ 0	$ 0	$ 0	$ 0
Cost of goods sold		0	0	0	0
Gross profit		0	0	0	0
Operating expenses:
Compensation		25	25	119	1,419
Professional fees		1,890	3,025	25,500	22,973
Office		9,225	7,841	21,632	19,377
Travel		1,236	158	1,614	551
Other		432	432	2,046	2,216
Total operating expenses		12,808	11,481	50,911	46,536
Loss from operations		(12,808)	(11,481)	(50,911)	(46,536)
Other income and (expense):
Interest expense		(528)	(2,392)	(2,677)	(6,963)
Gain (Loss) on Extinguishment of Debt		0	0	3,834	0
Net other expense		(528)	(2,392)	1,157	(6,963)
Loss before income taxes		(13,336)	(13,873)	(49,754)	(53,499)
Provision for income taxes		0	0	0	0
Net Loss		$ (13,336)	$ (13,873)	$ (49,754)	$ (53,499)
Basic and diluted loss per common share	[1]	$ 0	$ 0	$ 0	$ 0
Weighted average number of common shares		275,353,601	255,395,824	272,236,342	250,078,046
[1]	*less than $0.01 per share

Statement of Stockholders' Defi

Statement of Stockholders' Deficit - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings	Total
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2017	$ 243,920	$ 7,788,248	$ (8,282,912)	$ (250,744)
Shares, Outstanding, Beginning Balance at Dec. 31, 2017	243,920,268
Stock Issued During Period, Value, Purchase of Assets	$ 6,800	9,050		15,850
Stock Issued During Period, Shares, Purchase of Assets	6,800,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(27,291)	(27,291)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2018	$ 250,720	7,797,298	(8,310,203)	(262,185)
Shares, Outstanding, Ending Balance at Mar. 31, 2018	250,720,268
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2017	$ 243,920	7,788,248	(8,282,912)	(250,744)
Shares, Outstanding, Beginning Balance at Dec. 31, 2017	243,920,268
Stock Issued During Period, Value, Purchase of Assets	$ 700	9,800		10,500
Stock Issued During Period, Shares, Purchase of Assets	700,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(13,873)	(13,873)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2018	$ 255,520	7,817,848	(8,336,411)	(263,043)
Shares, Outstanding, Ending Balance at Sep. 30, 2018	250,520,268
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2018	$ 250,720	7,797,298	(8,310,203)	(262,185)
Shares, Outstanding, Beginning Balance at Mar. 31, 2018	250,720,268
Stock Issued During Period, Value, Purchase of Assets	$ 4,100	10,750		14,850
Stock Issued During Period, Shares, Purchase of Assets	4,100,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(12,335)	(12,335)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2018	$ 254,820	7,808,048	(8,322,538)	(259,670)
Shares, Outstanding, Ending Balance at Jun. 30, 2018	254,820,268
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2018	$ 267,020	7,878,798	(8,350,212)	(204,394)
Shares, Outstanding, Beginning Balance at Dec. 31, 2018	267,020,268
Stock Issued During Period, Value, Purchase of Assets	$ 1,800	7,200		9,000
Stock Issued During Period, Shares, Purchase of Assets	1,800,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(29,355)	(29,355)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2019	$ 268,820	7,885,998	(8,379,567)	(224,749)
Shares, Outstanding, Ending Balance at Mar. 31, 2019	820,268
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2018	$ 267,020	7,878,798	(8,350,212)	(204,394)
Shares, Outstanding, Beginning Balance at Dec. 31, 2018	267,020,268
Stock Issued During Period, Value, Purchase of Assets	$ 1,000	15,000		16,000
Stock Issued During Period, Shares, Purchase of Assets	1,000,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(13,336)	(13,336)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2019	$ 276,020	7,927,800	(8,399,966)	(196,146)
Shares, Outstanding, Ending Balance at Sep. 30, 2019	276,020,268
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2019	$ 268,820	7,885,998	(8,379,567)	(224,749)
Shares, Outstanding, Beginning Balance at Mar. 31, 2019	820,268
Stock Issued During Period, Value, Purchase of Assets	$ 6,200	26,802		33,002
Stock Issued During Period, Shares, Purchase of Assets	6,200,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(7,063)	(7,063)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2019	$ 275,020	$ 7,912,800	$ (8,386,630)	$ (198,810)
Shares, Outstanding, Ending Balance at Jun. 30, 2019	275,020,268

Statement of Stockholders Defic

Statement of Stockholders Deficit (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings	Total
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2017	$ 243,920	$ 7,788,248	$ (8,282,912)	$ (250,744)
Shares, Outstanding, Beginning Balance at Dec. 31, 2017	243,920,268
Stock Issued During Period, Value, Purchase of Assets	$ 6,800	9,050		15,850
Stock Issued During Period, Shares, Purchase of Assets	6,800,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(27,291)	(27,291)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2018	$ 250,720	7,797,298	(8,310,203)	(262,185)
Shares, Outstanding, Ending Balance at Mar. 31, 2018	250,720,268
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2017	$ 243,920	7,788,248	(8,282,912)	(250,744)
Shares, Outstanding, Beginning Balance at Dec. 31, 2017	243,920,268
Stock Issued During Period, Value, Purchase of Assets	$ 700	9,800		10,500
Stock Issued During Period, Shares, Purchase of Assets	700,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(13,873)	(13,873)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2018	$ 255,520	7,817,848	(8,336,411)	(263,043)
Shares, Outstanding, Ending Balance at Sep. 30, 2018	250,520,268
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2018	$ 250,720	7,797,298	(8,310,203)	(262,185)
Shares, Outstanding, Beginning Balance at Mar. 31, 2018	250,720,268
Stock Issued During Period, Value, Purchase of Assets	$ 4,100	10,750		14,850
Stock Issued During Period, Shares, Purchase of Assets	4,100,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(12,335)	(12,335)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2018	$ 254,820	7,808,048	(8,322,538)	(259,670)
Shares, Outstanding, Ending Balance at Jun. 30, 2018	254,820,268
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2018	$ 267,020	7,878,798	(8,350,212)	(204,394)
Shares, Outstanding, Beginning Balance at Dec. 31, 2018	267,020,268
Stock Issued During Period, Value, Purchase of Assets	$ 1,800	7,200		9,000
Stock Issued During Period, Shares, Purchase of Assets	1,800,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(29,355)	(29,355)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Mar. 31, 2019	$ 268,820	7,885,998	(8,379,567)	(224,749)
Shares, Outstanding, Ending Balance at Mar. 31, 2019	820,268
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2018	$ 267,020	7,878,798	(8,350,212)	(204,394)
Shares, Outstanding, Beginning Balance at Dec. 31, 2018	267,020,268
Stock Issued During Period, Value, Purchase of Assets	$ 1,000	15,000		16,000
Stock Issued During Period, Shares, Purchase of Assets	1,000,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(13,336)	(13,336)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2019	$ 276,020	7,927,800	(8,399,966)	(196,146)
Shares, Outstanding, Ending Balance at Sep. 30, 2019	276,020,268
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Mar. 31, 2019	$ 268,820	7,885,998	(8,379,567)	(224,749)
Shares, Outstanding, Beginning Balance at Mar. 31, 2019	820,268
Stock Issued During Period, Value, Purchase of Assets	$ 6,200	26,802		33,002
Stock Issued During Period, Shares, Purchase of Assets	6,200,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 0	0	(7,063)	(7,063)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Jun. 30, 2019	$ 275,020	$ 7,912,800	$ (8,386,630)	$ (198,810)
Shares, Outstanding, Ending Balance at Jun. 30, 2019	275,020,268

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Cash Flows from Operating Activities:
Net loss	$ (7,063)	$ (29,355)	$ (12,335)	$ (27,291)	$ (13,336)	$ (13,873)
Cash Flows from Financing Activities:
Proceeds from sale of common stock					58,002		$ 113,650
Cash and Cash Equivalents, at Carrying Value, Beginning Balance		$ 17,583			17,583
Cash and Cash Equivalents, at Carrying Value, Ending Balance					$ 9,096	$ 5,498	$ 17,583

Note 1. Nature of Operations

Note 1. Nature of Operations	9 Months Ended
	Sep. 30, 2019
Notes
Note 1. Nature of Operations	Note 1. Nature of Operations Company Overview The operations of Advanced Voice Recognition Systems, Inc. (“AVRS” or the “Company”), http://www.avrsys.com, commenced in 1994 with a predecessor entity called NCC, Inc. NCC, Inc. was incorporated on March 15, 1994 in the State of Ohio. NCC, Inc. operated as a software and hardware development company that marketed voice recognition and transcription products for commercial applications. In May 2000, WG Investments, LLC acquired the assets of NCC, Inc. and subsequently changed its name to NCC, LLC. NCC, LLC (also a predecessor to AVRS) continued the operations of NCC, Inc. until approximately December 31, 2001, when shifts in the industry’s markets caused NCC, LLC to suspend its operations. AVRS was incorporated in the State of Colorado on July 7, 2005. In September 2005, the members of NCC, LLC transferred all of their membership interests in NCC, LLC to AVRS in exchange for 93,333,333 shares (post-recapitalization) of AVRS common stock. In December 2005, the Board of Directors approved a 1.5-to-1 stock split issuing 46,666,667 common shares (post-recapitalization), which increased the number of common shares outstanding to 140 million shares (post-capitalization). Following the incorporation of AVRS, the Company initiated a new business plan and intends to continue its operations in the voice recognition and transcription industry. AVRS is a software development company specializing in speech recognition technologies. AVRS has successfully obtained patent protection of its proprietary technology (refer to Note 3, Intangible Assets). The Company has currently engaged a firm to investigate and assert claims relating to certain patents including negotiating licensing agreements and the filing and prosecution of lawsuits. Stock Purchase Agreements During the year ended December 31, 2018 the Company entered into Stock Purchase Agreements for the private sale to five persons or entities of an aggregate of 23,100,000 shares of the common stock for aggregate proceeds of $113,650, full payment of which was received in the period. During the nine months ended September 30, 2019, the Company entered into Stock Purchase Agreements for the private sale of an aggregate of 9,000,000 shares of the common stock for aggregate proceeds of $58,002 full payment of which was received in the period. Commitments and Contingencies On April 20, 2015 Advanced Voice Recognition Systems, Inc. (“AVRS”) entered into a Material Letter Agreement with an unrelated third party (“AIP”) in which they promise to pay to patent legal counsel funds to continue prosecuting Patents on behalf of AVRS. AVRS promises to pay AIP, or to such other holder of this promissory note (Note) as designate, the principal, together with a premium of ten percent (10%) of Principle and two percent (2%) of proceeds received by Company from a Monetization Event initiated by AIP. Interest was accrued and reported at September 30, 2019. On August 20, 2015, Advanced Voice Recognition Systems, Inc. (“AVRS”) entered into a letter agreement with unrelated third party (Third Party) pursuant to which the Third Party will provide strategic advisory services to AVRS to support the common goal of the acquisition, sale, licensing, prosecution, enforcement, and settlement with respect to AVRS’s intellectual property, including patents held by AVRS. The Third Party has agreed to advance costs recommended by it, including court filing fees, discovery and other litigation costs, and patent prosecution costs, up to an aggregate of $10,000,000. AVRS will be responsible for costs not recommended by the Third Party, as well as travel and ordinary business expenses incurred by AVRS. Except for the advanced costs by the Third Party, AVRS will be responsible for any contingency payments to law firms. Any and all advanced costs will only become liabilities if successful. On June 28, 2017 AVRS and the Third Party agreed to terminate the August 20, 2015 Letter Agreement. AVRS did not incur any material early termination penalties in connection of the early termination of the agreement. On November 1, 2016, Advanced Voice Recognition Systems, Inc. (“ AVRS Agreement Patent Rights responsibility for the costs and expenses in the Terminated August 20, 2015 Letter Agreement and provides for the payment of twenty percent (20%) of all gross Licensing Agreement Proceeds and thirty percent (30%) of all Litigation Proceeds received by AVRS. In addition if the Litigation Proceeds agreed to or received by AVRS at any time are $100,000 or less then Legal Representative shall receive forty percent (40%) of the Litigation Proceeds. On November 6, 2017 Advanced Voice Recognition Systems, Inc (“AVRS”) received notice that Meyers & Associates, LLC filed Complaint number 2017CV32482 in Arapahoe County District Court on October 30, 2017. The Complaint relates to purported legal fees owed by AVRS. On January 31, 2018 AVRS entered into a Settlement Agreement and Promissory Note with Meyers & Associates, LLC. AVRS promises to pay the principal sum of Fifty-Two Thousand Three Hundred Eighty-Five Dollars and Forty-Six Cents ($52,385.46) as well as accrued interest. AVRS shall pay $1,000 per month on the first day of each month beginning February 1, 2018 and continuing through July 1, 2018 and pay all remaining unpaid principal and accrued interest (12% annual) on August 1, 2018. All payments have been made. On August 1, 2018 AVRS and Meyers & Associates entered into an Agreement to Amend Promissory Note. AVRS shall pay $6,000 on or before August 1, 2018, shall pay $1,500 on the first day of each month beginning September 1, 2018 and continuing through November 1, 2018 and shall pay all remaining unpaid principal and accrued interest on December 1, 2018. All payments have been made. On November 21, 2018 AVRS and Meyers & Associates entered into a Second Agreement to Amend Promissory Note. AVRS shall pay $20,000 on or before November 21, 2018, shall pay $1,500 on the first day of each month beginning January 1, 2019 and continuing through June 1, 2019 and shall pay all remaining principle and interest on July 1, 2019. On June 7, 2019 the Company made the final payment of $11,046.74. The note is paid in full. A $1,500 gain from early extinguishment of Note Payable was reported as income on June 30, 2019. On June 21, 2018, Advanced Voice Recognition Systems, Inc. (“ AVRS Agreement the Firm On July 22, 2019 Apple, Inc. submitted a petition for Inter Partes Review (IPR) of the AVRS patent. It was ordered in the case of AVRS, Inc. v. Apple Inc (Case No. 2-18-cv-2083) that the parties’ stipulation was granted and the case is stayed pending the resolution of the IPR proceeding. Buether Joe and Carpenter, LLC (BJC), our representation in the AVRS v. Apple litigation will represent AVRS in the IPR. The IPR response to the Patent Trial and Appeal Board (PTAB) is due November 8, 2019.

Note 2. Significant Accounting

Note 2. Significant Accounting Policies	9 Months Ended
	Sep. 30, 2019
Notes
Note 2. Significant Accounting Policies	Note 2. Significant Accounting Policies Unaudited Financial Information The accompanying financial information at September 30, 2019 and for the nine months ended September 30, 2019 and 2018 is unaudited. In the opinion of management, all normal and recurring adjustments which are necessary to provide a fair presentation of the Company’s financial position at September 30, 2019 and its operating results for the nine months ended September 30, 2019 and 2018 have been made. Certain information and footnote data necessary for a fair presentation of financial position and results of operations in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted. It is therefore suggested that these financial statements be read in conjunction with the summary of significant accounting policies and notes to financial statements included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) for the year ended December 31, 2018. The results of operations for the nine months ended September 30, 2019 are not necessarily an indication of operating results to be expected for the year ending December 31, 2019. Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Liabilities exceed assets and there is a capital deficiency of $196,146 and no significant revenues. The Company may be unable to continue as a going concern for a reasonable period of time. The financial statements do not include any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis and ultimately to attain profitability. During the twelve months ended December 31, 2018 the Company received an aggregate of $113,650 from the sale of shares in private offerings of its common stock. During the nine months ended September 30, 2019 the Company received an aggregate of $58,002 from the sale of shares in private offerings of its common stock. The Company’s current operations are related to patent monetization and filing of additional patents. The Company has entered into a letter agreement with Dominion Harbor Group, LLC to provide strategic advisory services to AVRS. Dominion has agreed to advanced costs up to an aggregate of $10,000,000. On June 28, 2017 the Company and Dominion agreed to terminate the August 20, 2015 Letter Agreement. The Company did not incur any material early termination penalties. In addition the Company has revised the Contingent Fee Agreement with Buether Joe & Carpenter, LLC which will represent AVRS in connection with investigating and asserting claims to the AVRS patents including licensing and litigation activities. Any and all advanced costs will only become liabilities if successful. On June 6, 2017 AVRS and BJC revised the Contingent Fee Agreement as it related to the termination of the August 20, 2015 Dominion Harbor Letter Agreement. There is no guarantee that AVRS will be able to provide the capital required for the Company to continue as a going concern. Use of Estimates The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid debt instruments with original maturities of three months or less when acquired to be cash equivalents. The Company had cash at September 30, 2019 of $9,096, $17,583 at December 31, 2018 and $5,498 cash at September 30, 2018. No amounts resulted from cash equivalents. Financial Instruments The carrying amounts of cash, receivables and current liabilities approximate fair value due to the short-term maturity of the instruments. Fixed Assets Fixed assets are stated at cost. Depreciation is calculated using the straight-line method over the estimated useful lives of the related assets, ranging from three to five years. Expenditures for additions and improvements are capitalized, while repairs and maintenance costs are expensed as incurred. The cost and related accumulated depreciation of property and equipment sold or otherwise disposed of are removed from the accounts and any gain or loss is recorded in the year of disposal. Income Taxes Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to differences between the recorded book basis and the tax basis of assets and liabilities for financial and income tax reporting. Deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income and tax credits that are available to offset future federal income taxes. The Company believes that its income tax filing positions and deductions will be sustained on audit and does not anticipate any adjustments that will result in a material adverse effect on the Company’s financial condition, results of operations, or cash flow. Therefore, no reserves for uncertain income tax positions have been recorded pursuant to ASC 740. Research and Development Costs Research and development costs are expensed in the period incurred . Patents, Deferred Costs and Amortization Patents consist of costs incurred to acquire issued patents. Amortization commences once a patent is granted. Costs incurred to acquire patents that have not been issued are reported as deferred costs. On April 3, 2018 U.S. Patent #9,934,786 entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols” was issued by the U.S patent and Trademark Office. Deferred costs of $4,575 were capitalized and amortization began in the period. The Company amortizes its patents over an estimated useful life of twenty years. Impairment and Disposal of Long-Lived Assets The Company evaluates the carrying value of its long-lived assets under the provisions of ASC 360-10 Property, Plant, and Equipment Loss per Common Share The Company reports net loss per share using a dual presentation of basic and diluted loss per share. Basic net loss per share excludes the impact of common stock equivalents. Diluted net loss per share utilizes the average market price per share when applying the treasury stock method in determining common stock equivalents. At September 30, 2019 and 2018, there were no variances between the basic and diluted loss per share as there were no potentially dilutive securities outstanding. Fair Value of Financial Instruments The carrying amounts of cash and current liabilities approximate fair value because of the short-term maturity of these items. These fair value estimates are subjective in nature and involve uncertainties and matters of significant judgment, and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect these estimates. We do not hold or issue financial instruments for trading purposes, nor do we utilize derivative instruments. The FASB Accounting Standards Codification (ASC) clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. It also requires disclosure about how fair value is determined for assets and liabilities and establishes a hierarchy for which these assets and liabilities must be grouped, based on significant levels of inputs as follows: Level 1: Quoted prices in active markets for identical assets or liabilities. Level 2: Quoted prices in active markets for similar assets and liabilities and inputs that are observable for the asset or liability. Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

Note 3. Intangible and Fixed As

Note 3. Intangible and Fixed Assets	9 Months Ended
	Sep. 30, 2019
Notes
Note 3. Intangible and Fixed Assets	Note 3. Intangible and Fixed Assets Intangible Assets The Company monitors the anticipated outcome of legal actions, and if it determines that the success of the defense of a patent is probable, and so long as the Company believes that the future economic benefit of the patent will be increased, the Company capitalizes external legal costs incurred in the defense of the patent. Upon successful defense of litigation, the amounts previously capitalized are amortized over the remaining life of the patent. On July 7, 2009, U.S. Patent # 7,558,730, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning on July 7, 2009 and ending 20 years from the application date of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended September 30, 2009 and the Company began amortization. AVRS filed a Complaint in the United States District Court Northern District for Arizona (Case No. 2-18-cv-2083) on July 3, 2018, and alleges that Apple products infringe U.S. Patent No. 7,558,730 entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols” (the “‘730 Patent”). On May 24, 2011, U.S. Patent #7,949,534, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning May 24, 2011 and ending 20 years from the application date of the parent application (U.S. Patent #7,558,730) of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended June 30, 2011 and the Company began amortization. On March 6, 2012, U.S. Patent #8,131,557, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning March 6, 2012 and ending 20 years from the application date of the parent application (U.S. Patent #7,558,730) of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended March 31, 2012 and the Company began amortization. On July 30, 2013, U.S. Patent #8,498,871, entitled “Dynamic Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning on July 30, 2013 and ending 20 years from the application date of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended September 30, 2013 and the Company began amortization. On September 22, 2015, U.S. Patent #9,142,217, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning September 22, 2015 and ending 20 years from the application date of the parent application (US Patent No. 7,558,730) of November 27, 2001, or November 27, 2021. The deferred fees were capitalized during the quarter ended September 30, 2015 and the Company began amortization. On April 3, 2018, U.S. Patent #9,934,786, entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols,” was issued by the U.S. Patent and Trademark Office. In accordance with 35 U.S.C. 154, the patent shall be for a term beginning April 3, 2018 and ending 20 years from the application date of the parent application (U.S. Patent #7,558,730) of November 27, 2001 or November 27, 2021. The deferred costs were capitalized during the quarter ended June 30, 2018 and the Company began amortization. Amortization at December 31, 2018 is as follows: SCHEDULE OF INTANGIBLE ASSETS Ended December 31, 2018 U.S. Patent # Carrying Value Amortization Balance 7,558,730 $ 58,277 44,574 13,703 7,949,534 3,365 2,426 939 8,131,557 5,092 3,568 1,524 8,498,871 21,114 13,715 7,399 9,142,217 35,068 18,882 16,186 9,934,786 4,575 936 3,639 $ 127,491 $ 84,101 $ 43,390 Amortization at September 30, 2019 is as follows: Ended September 30, 2019 U.S. Patent # Carrying Value Amortization Balance 7,558,730 $ 58,277 48,093 10,184 7,949,534 3,365 2,660 705 8,131,557 5,092 3,961 1,131 8,498,871 21,114 15,614 5,500 9,142,217 35,068 22,929 12,139 9,934,786 4,575 1,872 2,703 $ 127,491 $ 95,129 $ 32,362 Amortization expense totaled $11,028 and $10,716 for the nine months ended September 30, 2019 and 2018. Estimated aggregate amortization expense for each of the next three years is as follows: SCHEDULE OF FUTURE AMORTIZATION Year ending September 30, 2019 3,675 2020 14,702 2021 13,985 $ 32,362 Fixed Assets Fixed assets were fully depreciated in the period ending December 31, 2018. PROPERTY PLANT AND EQUIPMENT December 31, 2018 Computer equipment $ 6,627 Computer software 3,640 10,267 Less accumulated depreciation (10,267) Property and Equipment, Net $ 0 September 30, 2019 September 30, 2018 Computer equipment $ 6,627 $ 6,627 Computer software 3,640 3,640 10,267 10,267 Less accumulated depreciation (10,267) (10,267) Property and Equipment, Net $ 0 $ 0

Note 4. Related Party Transacti

Note 4. Related Party Transactions	9 Months Ended
	Sep. 30, 2019
Notes
Note 4. Related Party Transactions	Note 4. Related Party Transactions Related Parties Transactions and Indebtedness The Company owed the officers aggregate of $162,382 at September 30, 2019 and December 31, 2018 for accrued payroll. During the period of nine months ending September 30, 2019, and September 30, 2018 the Company paid gross payroll of $119 and $1,419 to the CEO and for payroll expenses. On September 24, 2018, Advanced Voice Recognition Systems, Inc., a Nevada corporation (“AVRS”, “we” or “us”), entered into Promissory Note with Walter Geldenhuys, who is our President, Chief Executive Officer and Chief Financial Officer, and who serves as a member of our Board of Directors. The Promissory Note is effective as of September 24, 2018 in the principal amount of $9,000 with a maturity date of the Promissory Note September 24, 2019. Interest at 4% per annum was charged and $232 was accrued at September 30, 2019. The Company repaid $2500 of the note on December 10, 2018 another $2500 of the note on April 30, 2019 and $1,000 on September 25, 2019 leaving a remaining balance of $3,000 at September 30, 2019. On February 1, 2019, Walter Geldenhuys advanced the Company $5,000. On April 30, 2019 the Company repaid the $5,000 advance. On August 13, 2019, Walter Geldenhuys advanced the Company $4000. The Company repaid the advance on August 30, 2019.

Note 5. Income Taxes

Note 5. Income Taxes	9 Months Ended
	Sep. 30, 2019
Notes
Note 5. Income Taxes	Note 5. Income Taxes A reconciliation of the U.S. statutory federal income tax rate to the effective rate is as follows. INCOME TAXES September 30, 2019 December 31, 2018 U.S. federal statutory graduated rate * 21.00% 21.00% State income tax rate, net of federal benefit 0.00% 0.00% Contributed services 0.00% 0.00% Costs capitalized under Section 195 -21.00% -21.00% Effective rate 0.00% 0.00% The Company is considered a start-up company for income tax purposes. As of September 30, 2019, the Company had not commenced its trade operations, so all costs were capitalized under Section 195. Accordingly, the Company had no net operating loss carry forwards at September 30, 2019.

Note 6 . Concentration of Risk

Note 6 . Concentration of Risk	9 Months Ended
	Sep. 30, 2019
Notes
Note 6 . Concentration of Risk	Note 6. Concentration of Risk Beginning March 31, 2010, through September 30, 2019, all noninterest-bearing transaction accounts are fully insured, regardless of the balance of $250,000, at all FDIC-insured institutions. On September 30, 2019, the Company had cash balances at one FDIC insured financial institution of $9,096 in non-interest bearing accounts that were fully insured by the FDIC.

Note 7. Note Payable & Accounts

Note 7. Note Payable & Accounts Payable	9 Months Ended
	Sep. 30, 2019
Notes
Note 7. Note Payable & Accounts Payable	Note 7. Note Payable & Accounts Payable On April 20, 2015 Advanced Voice Recognition Systems, Inc. (AVRS) entered into a Material Letter Agreement with an unrelated third party AIP” in which they promise to pay to patent legal counsel funds to continue prosecuting Patents on behalf of AVRS. AVRS promises to pay AIP, or to such other holder of this promissory note (Note) as designate, the principal, together with a premium of ten percent (10%) of Principle and two percent (2%) of proceeds received by Company from a Monetization Event initiated by AIP. Interest was accrued and reported at September 30, 2019. On January 31, 2018 AVRS entered into a Settlement Agreement and Promissory Note with Meyers & Associates, LLC. AVRS promises to pay the principal sum of Fifty-Two Thousand Three Hundred Eighty-Five Dollars and Forty-Six Cents ($52,385.46) as well as accrued interest. AVRS shall pay $1,000 per month on the first day of each month beginning February 1, 2018 and continuing through July 1, 2018 and pay all remaining unpaid principal and accrued interest (12% annual) on August 1, 2018. All payments have been paid. On August 1, 2018 AVRS and Meyers & Associates entered into an Agreement to Amend Promissory Note. AVRS shall pay $6,000 on or before August 1, 2018, shall pay $1,500 on the first day of each month beginning September 1, 2018 and continuing through November 1, 2018 and shall pay all remaining unpaid principal and accrued interest on December 1, 2018. All payments have been made. On November 21, 2018 AVRS and Meyers & Associates entered into a Second Agreement to Amend Promissory Note. AVRS shall pay $20,000 on or before November 21, 2018, shall pay $1,500 on the first day of each month beginning January 1, 2019 and continuing through June 1, 2019 and shall pay all remaining principle and interest on July 1, 2019. On June 7, 2019 the final payment of $11,046.74 was made and the note was paid in full. A $1,500 gain from early extinguishment of Note Payable was reported as income on June 30, 2019. On April 8, 2019 AVRS recognized a gain on settlement of accounts payable of $2,334 which was reported as income on June 30, 2019.

Note 8. Stockholder Equity _ (D

Note 8. Stockholder Equity / (Deficit)	9 Months Ended
	Sep. 30, 2019
Notes
Note 8. Stockholder Equity / (Deficit)	Note 8. Stockholder Equity / (Deficit) The Company has issued shares of its common stock pursuant to certain agreements as described in Note 1.

Note 9 . Subsequent Events

Note 9 . Subsequent Events	9 Months Ended
	Sep. 30, 2019
Notes
Note 9 . Subsequent Events	Note 9. Subsequent Events None

Note 2. Significant Accountin_2

Note 2. Significant Accounting Policies: Unaudited Financial Information (Policies)	9 Months Ended
	Sep. 30, 2019
Policies
Unaudited Financial Information	Unaudited Financial Information The accompanying financial information at September 30, 2019 and for the nine months ended September 30, 2019 and 2018 is unaudited. In the opinion of management, all normal and recurring adjustments which are necessary to provide a fair presentation of the Company’s financial position at September 30, 2019 and its operating results for the nine months ended September 30, 2019 and 2018 have been made. Certain information and footnote data necessary for a fair presentation of financial position and results of operations in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted. It is therefore suggested that these financial statements be read in conjunction with the summary of significant accounting policies and notes to financial statements included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) for the year ended December 31, 2018. The results of operations for the nine months ended September 30, 2019 are not necessarily an indication of operating results to be expected for the year ending December 31, 2019.

Note 2. Significant Accountin_3

Note 2. Significant Accounting Policies: Going Concern (Policies)	9 Months Ended
	Sep. 30, 2019
Policies
Going Concern	Going Concern The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Liabilities exceed assets and there is a capital deficiency of $196,146 and no significant revenues. The Company may be unable to continue as a going concern for a reasonable period of time. The financial statements do not include any adjustments relating to the recoverability and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations on a timely basis and ultimately to attain profitability. During the twelve months ended December 31, 2018 the Company received an aggregate of $113,650 from the sale of shares in private offerings of its common stock. During the nine months ended September 30, 2019 the Company received an aggregate of $58,002 from the sale of shares in private offerings of its common stock. The Company’s current operations are related to patent monetization and filing of additional patents. The Company has entered into a letter agreement with Dominion Harbor Group, LLC to provide strategic advisory services to AVRS. Dominion has agreed to advanced costs up to an aggregate of $10,000,000. On June 28, 2017 the Company and Dominion agreed to terminate the August 20, 2015 Letter Agreement. The Company did not incur any material early termination penalties. In addition the Company has revised the Contingent Fee Agreement with Buether Joe & Carpenter, LLC which will represent AVRS in connection with investigating and asserting claims to the AVRS patents including licensing and litigation activities. Any and all advanced costs will only become liabilities if successful. On June 6, 2017 AVRS and BJC revised the Contingent Fee Agreement as it related to the termination of the August 20, 2015 Dominion Harbor Letter Agreement. There is no guarantee that AVRS will be able to provide the capital required for the Company to continue as a going concern.

Note 2. Significant Accountin_4

Note 2. Significant Accounting Policies: Use of Estimates (Policies)	9 Months Ended
	Sep. 30, 2019
Policies
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Note 2. Significant Accountin_5

Note 2. Significant Accounting Policies: Cash and Cash Equivalents (Policies)	9 Months Ended
	Sep. 30, 2019
Policies
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid debt instruments with original maturities of three months or less when acquired to be cash equivalents. The Company had cash at September 30, 2019 of $9,096, $17,583 at December 31, 2018 and $5,498 cash at September 30, 2018. No amounts resulted from cash equivalents.

Note 2. Significant Accountin_6

Note 2. Significant Accounting Policies: Financial Instruments (Policies)	9 Months Ended
	Sep. 30, 2019
Policies
Financial Instruments	Financial Instruments The carrying amounts of cash, receivables and current liabilities approximate fair value due to the short-term maturity of the instruments.

Note 2. Significant Accountin_7

Note 2. Significant Accounting Policies: Fixed Assets (Policies)	9 Months Ended
	Sep. 30, 2019
Policies
Fixed Assets	Fixed Assets Fixed assets are stated at cost. Depreciation is calculated using the straight-line method over the estimated useful lives of the related assets, ranging from three to five years. Expenditures for additions and improvements are capitalized, while repairs and maintenance costs are expensed as incurred. The cost and related accumulated depreciation of property and equipment sold or otherwise disposed of are removed from the accounts and any gain or loss is recorded in the year of disposal.

Note 2. Significant Accountin_8

Note 2. Significant Accounting Policies: Income Taxes (Policies)	9 Months Ended
	Sep. 30, 2019
Policies
Income Taxes	Income Taxes Income taxes are provided for the tax effects of transactions reported in the financial statements and consist of taxes currently due plus deferred taxes related primarily to differences between the recorded book basis and the tax basis of assets and liabilities for financial and income tax reporting. Deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income and tax credits that are available to offset future federal income taxes. The Company believes that its income tax filing positions and deductions will be sustained on audit and does not anticipate any adjustments that will result in a material adverse effect on the Company’s financial condition, results of operations, or cash flow. Therefore, no reserves for uncertain income tax positions have been recorded pursuant to ASC 740.

Note 2. Significant Accountin_9

Note 2. Significant Accounting Policies: Research and Development Costs (Policies)	9 Months Ended
	Sep. 30, 2019
Policies
Research and Development Costs	Research and development costs are expensed in the period incurred

Note 2. Significant Accounti_10

Note 2. Significant Accounting Policies: Patents, Deferred Costs and Amortization (Policies)	9 Months Ended
	Sep. 30, 2019
Policies
Patents, Deferred Costs and Amortization	Patents, Deferred Costs and Amortization Patents consist of costs incurred to acquire issued patents. Amortization commences once a patent is granted. Costs incurred to acquire patents that have not been issued are reported as deferred costs. On April 3, 2018 U.S. Patent #9,934,786 entitled “Speech Recognition and Transcription Among Users Having Heterogeneous Protocols” was issued by the U.S patent and Trademark Office. Deferred costs of $4,575 were capitalized and amortization began in the period. The Company amortizes its patents over an estimated useful life of twenty years.

Note 2. Significant Accounti_11

Note 2. Significant Accounting Policies: Impairment and Disposal of Long-Lived Assets (Policies)	9 Months Ended
	Sep. 30, 2019
Policies
Impairment and Disposal of Long-Lived Assets	Impairment and Disposal of Long-Lived Assets The Company evaluates the carrying value of its long-lived assets under the provisions of ASC 360-10 Property, Plant, and Equipment

Note 2. Significant Accounti_12

Note 2. Significant Accounting Policies: Loss per Common Share (Policies)	9 Months Ended
	Sep. 30, 2019
Policies
Loss per Common Share	Loss per Common Share The Company reports net loss per share using a dual presentation of basic and diluted loss per share. Basic net loss per share excludes the impact of common stock equivalents. Diluted net loss per share utilizes the average market price per share when applying the treasury stock method in determining common stock equivalents. At September 30, 2019 and 2018, there were no variances between the basic and diluted loss per share as there were no potentially dilutive securities outstanding.

Note 2. Significant Accounti_13

Note 2. Significant Accounting Policies: Fair Value of Financial Instruments (Policies)	9 Months Ended
	Sep. 30, 2019
Policies
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying amounts of cash and current liabilities approximate fair value because of the short-term maturity of these items. These fair value estimates are subjective in nature and involve uncertainties and matters of significant judgment, and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect these estimates. We do not hold or issue financial instruments for trading purposes, nor do we utilize derivative instruments. The FASB Accounting Standards Codification (ASC) clarifies that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. It also requires disclosure about how fair value is determined for assets and liabilities and establishes a hierarchy for which these assets and liabilities must be grouped, based on significant levels of inputs as follows: Level 1: Quoted prices in active markets for identical assets or liabilities. Level 2: Quoted prices in active markets for similar assets and liabilities and inputs that are observable for the asset or liability. Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.

Note 3. Intangible and Fixed _2

Note 3. Intangible and Fixed Assets: Schedule of Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2019
Tables/Schedules
Schedule of Intangible Assets	Ended December 31, 2018 U.S. Patent # Carrying Value Amortization Balance 7,558,730 $ 58,277 44,574 13,703 7,949,534 3,365 2,426 939 8,131,557 5,092 3,568 1,524 8,498,871 21,114 13,715 7,399 9,142,217 35,068 18,882 16,186 9,934,786 4,575 936 3,639 $ 127,491 $ 84,101 $ 43,390 Amortization at September 30, 2019 is as follows: Ended September 30, 2019 U.S. Patent # Carrying Value Amortization Balance 7,558,730 $ 58,277 48,093 10,184 7,949,534 3,365 2,660 705 8,131,557 5,092 3,961 1,131 8,498,871 21,114 15,614 5,500 9,142,217 35,068 22,929 12,139 9,934,786 4,575 1,872 2,703 $ 127,491 $ 95,129 $ 32,362

Note 3. Intangible and Fixed _3

Note 3. Intangible and Fixed Assets: Schedule of Future Amortization (Tables)	9 Months Ended
	Sep. 30, 2019
Tables/Schedules
Schedule of Future Amortization	SCHEDULE OF FUTURE AMORTIZATION Year ending September 30, 2019 3,675 2020 14,702 2021 13,985 $ 32,362

Note 3. Intangible and Fixed _4

Note 3. Intangible and Fixed Assets: Property Plant and Equipment Text Block (Tables)	9 Months Ended
	Sep. 30, 2019
Tables/Schedules
Property Plant and Equipment Text Block	PROPERTY PLANT AND EQUIPMENT December 31, 2018 Computer equipment $ 6,627 Computer software 3,640 10,267 Less accumulated depreciation (10,267) Property and Equipment, Net $ 0 September 30, 2019 September 30, 2018 Computer equipment $ 6,627 $ 6,627 Computer software 3,640 3,640 10,267 10,267 Less accumulated depreciation (10,267) (10,267) Property and Equipment, Net $ 0 $ 0

Note 5. Income Taxes_ Income Ta

Note 5. Income Taxes: Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2019
Tables/Schedules
Income Taxes	INCOME TAXES September 30, 2019 December 31, 2018 U.S. federal statutory graduated rate * 21.00% 21.00% State income tax rate, net of federal benefit 0.00% 0.00% Contributed services 0.00% 0.00% Costs capitalized under Section 195 -21.00% -21.00% Effective rate 0.00% 0.00%

Note 2. Significant Accounti_14

Note 2. Significant Accounting Policies: Going Concern (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Details
Proceeds from sale of common stock	$ 58,002	$ 113,650

Note 2. Significant Accounti_15

Note 2. Significant Accounting Policies: Cash and Cash Equivalents (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018	Sep. 30, 2018
Details
Cash and cash equivalents	$ 9,096	$ 17,583	$ 5,498

Note 3. Intangible and Fixed _5

Note 3. Intangible and Fixed Assets: Schedule of Intangible Assets (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018
U.S. Patent # 7,558,730
Carrying Value	$ 58,277	$ 58,277
Amortization	48,093	44,574
Balance	10,184	13,703
U.S. Patent # 7,949,534
Carrying Value	3,365	3,365
Amortization	2,660	2,426
Balance	705	939
U.S. Patent # 8,131,557
Carrying Value	5,092	5,092
Amortization	3,961	3,568
Balance	1,131	1,524
U.S. Patent # 8,498,871
Carrying Value	21,114	21,114
Amortization	15,614	13,715
Balance	5,500	7,399
U.S. Patent # 9,142,217
Carrying Value	35,068	35,068
Amortization	22,929	18,882
Balance	12,139	16,186
U.S. Patent # 9,934,786
Carrying Value	4,575	4,575
Amortization	1,872	936
Balance	$ 2,703	$ 3,639

Note 3. Intangible and Fixed _6

Note 3. Intangible and Fixed Assets: Schedule of Future Amortization (Details)	Sep. 30, 2019USD ($)
Details
2019	$ 3,675
2020	14,702
2021	13,985
Balance	$ 32,362

Note 3. Intangible and Fixed _7

Note 3. Intangible and Fixed Assets: Property Plant and Equipment Text Block (Details) - USD ($)	Sep. 30, 2019	Sep. 30, 2018
Details
Computer equipment	$ 6,627	$ 6,627
Computer software	3,640	3,640
Less accumulated depreciation	(10,267)	(10,267)
Property and Equipment, Net	$ 0	$ 0

Note 4. Related Party Transac_2

Note 4. Related Party Transactions (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Details
Payroll	$ 162,382		$ 162,382		$ 162,382
Compensation	$ 25	$ 25	$ 119	$ 1,419

Note 5. Income Taxes_ Income _2

Note 5. Income Taxes: Income Taxes (Details)	Sep. 30, 2019	Dec. 31, 2018
Details
U.S. federal statutory graduated rate	21.00%	21.00%
State income tax rate, net of federal benefit	0.00%	0.00%
Contributed services	0.00%	0.00%
Costs capitalized under Section 195	(21.00%)	(21.00%)
Effective rate	0.00%	0.00%

Note 5. Income Taxes (Details)

Note 5. Income Taxes (Details)	Sep. 30, 2019USD ($)
Details
Operating Loss Carryforwards	$ 0

Note 6 . Concentration of Risk

Note 6 . Concentration of Risk (Details) - USD ($)	Sep. 30, 2019	Dec. 31, 2018	Sep. 30, 2018
Details
Cash and cash equivalents	$ 9,096	$ 17,583	$ 5,498